Video: Video Gallery
GSK warns China scandal will hurt (2:00)
July 24 - British drugmaker, GlaxoSmithKline, marred by bribery allegations in China, is announcing its second quarter results. Joanne Nicholson looks at whether the company will be able to offset damage to GSK’s reputation and help calm the waters for other pharmaceuticals being drawn into the affair ( Transcript )
Hard-edged reporting, insight and analysis, Reuters TV breaks ground creating informative news and financial videos. Showcasing Reuters’ 3000 award-winning journalists, Reuters TV delivers high-energy investigative journalism with concise explanations. Check it out and let us know what you think.